Your browser doesn't support javascript.
loading
Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate Vaccine.
Duke, Jeremy A; Paschall, Amy V; Robinson, Lloyd S; Knoot, Cory J; Vinogradov, Evgeny; Scott, Nichollas E; Feldman, Mario F; Avci, Fikri Y; Harding, Christian M.
Afiliação
  • Duke JA; Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 30602, United States.
  • Paschall AV; Center for Molecular Medicine, University of Georgia, Athens, Georgia 30602, United States.
  • Robinson LS; Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 30602, United States.
  • Knoot CJ; Center for Molecular Medicine, University of Georgia, Athens, Georgia 30602, United States.
  • Vinogradov E; VaxNewMo, St. Louis, Missouri 63110, United States.
  • Scott NE; VaxNewMo, St. Louis, Missouri 63110, United States.
  • Feldman MF; Human Health Therapeutics Centre, National Research Council Canada, Ottawa, ON K1A 0R6, Canada.
  • Avci FY; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3010, Australia.
  • Harding CM; VaxNewMo, St. Louis, Missouri 63110, United States.
ACS Infect Dis ; 7(11): 3111-3123, 2021 11 12.
Article em En | MEDLINE | ID: mdl-34633812

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estreptocócicas / Escherichia coli Limite: Adult / Humans / Newborn Idioma: En Revista: ACS Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estreptocócicas / Escherichia coli Limite: Adult / Humans / Newborn Idioma: En Revista: ACS Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos